VRSN
58
2
TDC
60
3
V
72
6
GME
65
2
UHS
60
-2
XEL
50
2
CTSH
51
6
QCOM
78
-6
ROK
48
-2
DOW
38
-2
TEL
75
-2
NEE
46
5
CNX
37
3
HUM
35
6
SYF
88
3
GOOGL
66
5
HSIC
42
-3
MCHP
49
-6
EA
50
-2
COP
42
3
VRSN
58
2
TDC
60
3
V
72
6
GME
65
2
UHS
60
-2
XEL
50
2
CTSH
51
6
QCOM
78
-6
ROK
48
-2
DOW
38
-2
TEL
75
-2
NEE
46
5
CNX
37
3
HUM
35
6
SYF
88
3
GOOGL
66
5
HSIC
42
-3
MCHP
49
-6
EA
50
-2
COP
42
3
Financhill
Back

Wynn Resorts Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
29

WYNN
Wynn Resorts

Last Price:
89.89
Seasonality Move:
4.52%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
29
Wynn Resorts (WYNN) is a Sell

Is Wynn Resorts a Buy, Sell or Hold?

  • The current Wynn Resorts [WYNN] share price is $89.70. The Score for WYNN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • WYNN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WYNN Stock Price Chart

What is Wynn Resorts's stock price today?

  • The Wynn Resorts share price today is $89.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WYNN is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

WYNN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.88 Sell
Relative Strength Index (14 RSI): 35.29 Sell
Chaikin Money Flow: -336887 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.64 - 95.96) Sell
Bollinger Bands (100): (94.01 - 103.37) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

WYNN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.3 Sell
20-day SMA: 92.34 Sell
50-day SMA: 95.4 Sell
200-day SMA: 94.71 Sell
8-day EMA: 90.26 Sell
20-day EMA: 92.13 Sell
50-day EMA: 94.82 Sell
200-day EMA: 96.2 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Wynn Resorts Earnings Growth & WYNN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.20 per share, an increase this year of $2.49 per share, and an increase next year of $0.42 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Wynn Resorts Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):